Fujifilm (OTCMKTS:FUJIY) Share Price Passes Above 200 Day Moving Average - What's Next?

Key Points

• Fujifilm's stock price has recently surpassed its ***200-day moving average*** of $10.57, trading as high as ***$11.97*** in a session with a volume of 111,146 shares.
• Wall Street Zen has downgraded Fujifilm from a ***"buy"*** to a ***"hold"*** rating on May 23rd, raising concerns about the stock's performance.
• The company reported ***$0.15 earnings per share*** for the last quarter, meeting analysts' expectations, with total revenue of ***$5.08 billion*** compared to far lower analyst estimates of $760.41 billion.

Fujifilm Holdings Corp. (OTCMKTS:FUJIY - Get Free Report) shares passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $10.57 and traded as high as $11.97. Fujifilm shares last traded at $11.93, with a volume of 111,146 shares trading hands.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered Fujifilm from a "buy" rating to a "hold" rating in a research report on Friday, May 23rd.

Fujifilm Price Performance

The stock has a market cap of $30.28 billion, a P/E ratio of 10.96, a PEG ratio of 2.33 and a beta of 0.67. The company has a 50 day simple moving average of $11.10 and a 200 day simple moving average of $10.61. The company has a current ratio of 1.48, a quick ratio of 0.92 and a debt-to-equity ratio of 0.17.

Fujifilm (OTCMKTS:FUJIY - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The technology company reported $0.15 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.15. Fujifilm had a return on equity of 7.60% and a net margin of 7.93%.The company had revenue of $5.08 billion for the quarter, compared to analysts' expectations of $760.41 billion. Sell-side analysts forecast that Fujifilm Holdings Corp. will post 0.66 earnings per share for the current fiscal year.

Fujifilm Company Profile

FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.